3 years ago
India saw its active coronavirus tally fall as recoveries outpaced new cases.
Sep 11, 2022 12:08 (IST)
DCGI had approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years.
iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with pre-fusion stabilised spike protein.
The vaccine was evaluated in phase 2 and 3 clinical trials with successful results.
Source: PTI
Sep 11, 2022 10:09 (IST)